Center news & funding
VCU Massey Cancer Center researchers have been awarded a grant totaling more than $1.4 million over four years from the National Cancer Institute (NCI) to drive the development of a new treatment for MYCN-amplified neuroblastoma, an aggressive subset of pediatric nervous system cancer marked by overexpression of the MYCN gene. There are limited treatments currently available for MYCN-amplified neuroblastoma, and it is among the deadliest of the pediatric cancers.
Massey awarded grant to collaborate with other elite cancer institutes on cutting-edge clinical trials
VCU Massey Cancer Center has received a UM1 sub-award from the National Cancer Institute to participate in the North American Star Consortium (NASC), an association of leading cancer institutes that collaborate on novel National Cancer Institute (NCI)-sponsored clinical trials featuring some of the most promising cancer therapies available.
Eleven VCU Massey Cancer Center research members will receive funding to quickly pivot or expand their work to address the impact of the COVID-19 pandemic on the health system and the community.
Massey researcher recognized for substantial contributions to the field of biostatistical research methodology and oral health epidemiology
Dipankar Bandyopadhyay, Ph.D., a research member at VCU Massey Cancer Center and the director of Massey’s Biostatistics Shared Resource core, has been selected by the Washington Statistical Society and RTI International as the 2020 Gertrude M. Cox awardee.
Robert Winn, M.D., began as director of VCU Massey Cancer Center in December 2019 and has quickly hit the ground running to enact an ambitious agenda. Since early March he has also led Massey’s response to the COVID-19 pandemic affecting the lives of many patients and families. Protecting cancer patients and team members has been his top priority during the rapidly evolving situation, but he is also working to ensure that Massey can continue its cancer research and laying the groundwork for his future vision.